Expert picks on key HIV data from CROI 2019, including pre-exposure prophylaxis (PrEP), first-line ART or switch, and treatment during pregnancy
Week 48 data from Study 380-1474 of BIC/FTC/TAF as maintenance ART in children and adolescents from CROI 2019 as reported by Clinical Care Options
Results from DolPHIN-2 trial comparing dolutegravir- vs efavirenz-based ART in late pregnancy from CROI 2019 as reported by Clinical Care Options.
Clinical Care Options slides. Expert insight on optimizing ART in newly diagnosed, stably suppressed, or treatment-experienced persons with HIV.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.